{"product_id":"thymosin-β4-fragment-17-24-10mg-vial","title":"Thymosin β4 Fragment 17–24 10mg vial","description":"\u003cp data-end=\"637\" data-start=\"75\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                                 \u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eFOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-end=\"637\" data-start=\"75\"\u003e\u003cstrong\u003e\"Frag 17–24\"\u003c\/strong\u003e refers to the \u003cstrong data-end=\"184\" data-start=\"135\"\u003eactin-binding core motif of thymosin β4 (Tβ4)\u003c\/strong\u003e—the octa\/heptapeptide sequence around \u003cstrong data-end=\"279\" data-start=\"223\"\u003eresidues 17–24 (canonical: LKKTETQE \/ 17–23 LKKTETQ)\u003c\/strong\u003e. This short fragment retains key \u003cstrong data-end=\"348\" data-start=\"313\"\u003ecell-migration and cytoskeletal\u003c\/strong\u003e activities attributed to full-length Tβ4 and is used in research under the colloquial name \u003cstrong data-end=\"450\" data-start=\"440\"\u003eTB-500\u003c\/strong\u003e (a Tβ4-derived fragment). It is explored for \u003cstrong data-end=\"586\" data-start=\"496\"\u003ewound repair, tendon\/ligament recovery, angiogenesis, and anti-inflammatory remodeling\u003c\/strong\u003e. No product in this class is \u003cstrong data-end=\"636\" data-start=\"616\"\u003eFDA\/EMA-approved\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-end=\"642\" data-start=\"639\"\u003e\n\u003ch3 data-end=\"724\" data-start=\"644\"\u003eAdditional Benefits of Tβ4 Frag 17–24 (TB-500-class) Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"2926\" data-start=\"726\"\u003e\n\u003cthead data-end=\"754\" data-start=\"726\"\u003e\n\u003ctr data-end=\"754\" data-start=\"726\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"736\" data-start=\"726\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"754\" data-start=\"736\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"2926\" data-start=\"765\"\u003e\n\u003ctr data-end=\"1091\" data-start=\"765\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"822\" data-start=\"765\"\u003e\u003cstrong data-end=\"821\" data-start=\"767\"\u003e1 Accelerated wound closure \u0026amp; re-epithelialization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1091\" data-start=\"822\" data-col-size=\"xl\"\u003eFragment promotes \u003cstrong data-end=\"868\" data-start=\"842\"\u003ekeratinocyte migration\u003c\/strong\u003e, \u003cstrong data-end=\"896\" data-start=\"870\"\u003elamellipodia formation\u003c\/strong\u003e, and \u003cstrong data-end=\"924\" data-start=\"902\"\u003egranulation tissue\u003c\/strong\u003e; topical or perilesional dosing shortens time-to-closure in animal cutaneous wounds. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Wound Repair \u0026amp; Regeneration; Journal of Investigative Dermatology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1314\" data-start=\"1092\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1137\" data-start=\"1092\"\u003e\u003cstrong data-end=\"1136\" data-start=\"1094\"\u003e2 Angiogenesis \u0026amp; perfusion restoration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1314\" data-start=\"1137\" data-col-size=\"xl\"\u003eUp-regulates \u003cstrong data-end=\"1160\" data-start=\"1152\"\u003eVEGF\u003c\/strong\u003e, \u003cstrong data-end=\"1172\" data-start=\"1162\"\u003eHIF-1α\u003c\/strong\u003e, and endothelial outgrowth, improving \u003cstrong data-end=\"1236\" data-start=\"1211\"\u003emicrovascular density\u003c\/strong\u003e in ischemic tissue models. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Circulation Research; Angiogenesis\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1584\" data-start=\"1315\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1347\" data-start=\"1315\"\u003e\u003cstrong data-end=\"1346\" data-start=\"1317\"\u003e3 Tendon\/ligament healing\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1584\" data-start=\"1347\" data-col-size=\"xl\"\u003eEnhances \u003cstrong data-end=\"1380\" data-start=\"1358\"\u003etenocyte migration\u003c\/strong\u003e, \u003cstrong data-end=\"1410\" data-start=\"1382\"\u003ecollagen I\/III alignment\u003c\/strong\u003e, and \u003cstrong data-end=\"1439\" data-start=\"1416\"\u003emechanical strength\u003c\/strong\u003e post-injury; synergy reported with eccentric-loading rehab. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;American Journal of Sports Medicine; Journal of Orthopaedic Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1809\" data-start=\"1585\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1622\" data-start=\"1585\"\u003e\u003cstrong data-end=\"1621\" data-start=\"1587\"\u003e4 Anti-inflammatory remodeling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1809\" data-start=\"1622\" data-col-size=\"xl\"\u003eDampens \u003cstrong data-end=\"1653\" data-start=\"1632\"\u003eNF-κB\/TNF-α\/IL-1β\u003c\/strong\u003e and shifts macrophages toward \u003cstrong data-end=\"1712\" data-start=\"1684\"\u003epro-resolving phenotypes\u003c\/strong\u003e, reducing edema and scar thickness. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Journal of Immunology; Inflammation Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2062\" data-start=\"1810\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1849\" data-start=\"1810\"\u003e\u003cstrong data-end=\"1848\" data-start=\"1812\"\u003e5 Cardioprotection (preclinical)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2062\" data-start=\"1849\" data-col-size=\"xl\"\u003eIn myocardial I\/R and chronic ischemia models, Tβ4-motif peptides reduce \u003cstrong data-end=\"1937\" data-start=\"1924\"\u003eapoptosis\u003c\/strong\u003e, enhance \u003cstrong data-end=\"1958\" data-start=\"1947\"\u003eAkt\/ILK\u003c\/strong\u003e signalling, and limit fibrosis—improving function. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Circulation; Cardiovascular Research\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2293\" data-start=\"2063\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2101\" data-start=\"2063\"\u003e\u003cstrong data-end=\"2100\" data-start=\"2065\"\u003e6 Corneal\/ocular surface repair\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2293\" data-start=\"2101\" data-col-size=\"xl\"\u003eSpeeds \u003cstrong data-end=\"2132\" data-start=\"2110\"\u003ecorneal epithelial\u003c\/strong\u003e healing and nerve regeneration with improved tear-film metrics in dry-eye\/keratitis models. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Investigative Ophthalmology \u0026amp; Visual Science; Cornea\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2485\" data-start=\"2294\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2331\" data-start=\"2294\"\u003e\u003cstrong data-end=\"2330\" data-start=\"2296\"\u003e7 Skeletal muscle regeneration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2485\" data-start=\"2331\" data-col-size=\"xl\"\u003eAugments \u003cstrong data-end=\"2370\" data-start=\"2342\"\u003esatellite-cell migration\u003c\/strong\u003e, \u003cstrong data-end=\"2393\" data-start=\"2372\"\u003emyotube formation\u003c\/strong\u003e, and vascular support after contusion\/strain. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;FASEB Journal; Muscle \u0026amp; Nerve\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2690\" data-start=\"2486\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2518\" data-start=\"2486\"\u003e\u003cstrong data-end=\"2517\" data-start=\"2488\"\u003e8 Anti-fibrotic signaling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2690\" data-start=\"2518\" data-col-size=\"xl\"\u003eLowers \u003cstrong data-end=\"2541\" data-start=\"2527\"\u003eTGF-β\/CTGF\u003c\/strong\u003e and disordered collagen deposition in skin and tendon, yielding \u003cstrong data-end=\"2628\" data-start=\"2606\"\u003emore elastic scars\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Matrix Biology; Fibrogenesis \u0026amp; Tissue Repair\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2926\" data-start=\"2691\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2735\" data-start=\"2691\"\u003e\u003cstrong data-end=\"2734\" data-start=\"2693\"\u003e9 Hair-follicle cycling (exploratory)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2926\" data-start=\"2735\" data-col-size=\"xl\"\u003eTβ4-derived sequences can \u003cstrong data-end=\"2782\" data-start=\"2763\"\u003eactivate anagen\u003c\/strong\u003e, increase \u003cstrong data-end=\"2801\" data-start=\"2793\"\u003eVEGF\u003c\/strong\u003e around follicles, and improve shaft calibre in murine models. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Experimental Dermatology; Dermatologic Therapy\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"2931\" data-start=\"2928\"\u003e\n\u003ch2 data-end=\"2968\" data-start=\"2933\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"3012\" data-start=\"2970\"\u003e2.1 Receptor\/Target Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-end=\"3389\" data-start=\"3013\"\u003eThe \u003cstrong data-end=\"3031\" data-start=\"3017\"\u003eLKKTETQ(E)\u003c\/strong\u003e motif \u003cstrong data-end=\"3055\" data-start=\"3038\"\u003ebinds G-actin\u003c\/strong\u003e, modulating actin sequestration and polymerization. Downstream, it engages \u003cstrong data-end=\"3163\" data-start=\"3131\"\u003eintegrin-linked kinase (ILK)\u003c\/strong\u003e and \u003cstrong data-end=\"3180\" data-start=\"3168\"\u003ePI3K–Akt\u003c\/strong\u003e, influences \u003cstrong data-end=\"3211\" data-start=\"3193\"\u003efocal-adhesion\u003c\/strong\u003e dynamics (FAK\/vinculin), and induces \u003cstrong data-end=\"3260\" data-start=\"3249\"\u003eMMP-2\/9\u003c\/strong\u003e for controlled matrix remodeling. Indirect effects include \u003cstrong data-end=\"3335\" data-start=\"3320\"\u003eVEGF\/HIF-1α\u003c\/strong\u003e induction and \u003cstrong data-end=\"3369\" data-start=\"3350\"\u003eNF-κB tempering\u003c\/strong\u003e in inflamed tissue.\u003c\/p\u003e\n\u003ch3 data-end=\"3418\" data-start=\"3391\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3975\" data-start=\"3420\"\u003e\n\u003cthead data-end=\"3462\" data-start=\"3420\"\u003e\n\u003ctr data-end=\"3462\" data-start=\"3420\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3430\" data-start=\"3420\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"3451\" data-start=\"3430\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3462\" data-start=\"3451\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3975\" data-start=\"3477\"\u003e\n\u003ctr data-end=\"3586\" data-start=\"3477\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3497\" data-start=\"3477\"\u003e\u003cstrong data-end=\"3496\" data-start=\"3479\"\u003eActin–ILK–Akt\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3545\" data-start=\"3497\" data-col-size=\"md\"\u003eCell migration, survival, cytoskeletal repair\u003c\/td\u003e\n\u003ctd data-end=\"3586\" data-start=\"3545\" data-col-size=\"sm\"\u003eKeratinocytes, tenocytes, endothelium\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3683\" data-start=\"3587\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3609\" data-start=\"3587\"\u003e\u003cstrong data-end=\"3608\" data-start=\"3589\"\u003eFAK\/MMP program\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3653\" data-start=\"3609\" data-col-size=\"md\"\u003eMatrix remodeling, sprouting angiogenesis\u003c\/td\u003e\n\u003ctd data-end=\"3683\" data-start=\"3653\" data-col-size=\"sm\"\u003eWound bed, tendon\/ligament\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3772\" data-start=\"3684\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3704\" data-start=\"3684\"\u003e\u003cstrong data-end=\"3703\" data-start=\"3686\"\u003eHIF-1α → VEGF\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3745\" data-start=\"3704\" data-col-size=\"md\"\u003eNeovascularization, improved perfusion\u003c\/td\u003e\n\u003ctd data-end=\"3772\" data-start=\"3745\" data-col-size=\"sm\"\u003eIschemic tissue, cornea\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3874\" data-start=\"3773\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3797\" data-start=\"3773\"\u003e\u003cstrong data-end=\"3796\" data-start=\"3775\"\u003eNF-κB down-tuning\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3840\" data-start=\"3797\"\u003e↓ TNF-α\/IL-1β, pro-resolving macrophages\u003c\/td\u003e\n\u003ctd data-end=\"3874\" data-start=\"3840\" data-col-size=\"sm\"\u003eInflamed wounds, tendon sheath\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3975\" data-start=\"3875\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3902\" data-start=\"3875\"\u003e\u003cstrong data-end=\"3901\" data-start=\"3877\"\u003eTGF-β\/CTGF restraint\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3953\" data-start=\"3902\" data-col-size=\"md\"\u003e↓ pathologic fibrosis, better collagen alignment\u003c\/td\u003e\n\u003ctd data-end=\"3975\" data-start=\"3953\" data-col-size=\"sm\"\u003eScar\/Tendon matrix\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3980\" data-start=\"3977\"\u003e\n\u003ch2 data-end=\"4004\" data-start=\"3982\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"4430\" data-start=\"4006\"\u003e\n\u003cli data-end=\"4147\" data-start=\"4006\"\u003e\n\u003cp data-end=\"4147\" data-start=\"4008\"\u003e\u003cstrong data-end=\"4031\" data-start=\"4008\"\u003eRoute\/formulations:\u003c\/strong\u003e Investigated \u003cstrong data-end=\"4085\" data-start=\"4045\"\u003esubcutaneous\/perilesional injections\u003c\/strong\u003e, \u003cstrong data-end=\"4113\" data-start=\"4087\"\u003etopical gels\/eye drops\u003c\/strong\u003e, and \u003cstrong data-end=\"4144\" data-start=\"4119\"\u003ebiomaterial dressings\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4260\" data-start=\"4148\"\u003e\n\u003cp data-end=\"4260\" data-start=\"4150\"\u003e\u003cstrong data-end=\"4164\" data-start=\"4150\"\u003eHalf-life:\u003c\/strong\u003e \u003cstrong data-end=\"4190\" data-start=\"4165\"\u003eShort (minutes–hours)\u003c\/strong\u003e; biological effects persist via transcriptional and matrix changes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4360\" data-start=\"4261\"\u003e\n\u003cp data-end=\"4360\" data-start=\"4263\"\u003e\u003cstrong data-end=\"4280\" data-start=\"4263\"\u003eDistribution:\u003c\/strong\u003e Predominantly \u003cstrong data-end=\"4304\" data-start=\"4295\"\u003elocal\u003c\/strong\u003e; systemic exposure limited unless high\/IV doses used.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4430\" data-start=\"4361\"\u003e\n\u003cp data-end=\"4430\" data-start=\"4363\"\u003e\u003cstrong data-end=\"4377\" data-start=\"4363\"\u003eClearance:\u003c\/strong\u003e Peptidase degradation; no CYP interactions expected.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"4435\" data-start=\"4432\"\u003e\n\u003ch2 data-end=\"4482\" data-start=\"4437\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-end=\"4524\" data-start=\"4484\"\u003e4.1 Cutaneous \u0026amp; Soft-tissue Repair\u003c\/h3\u003e\n\u003cp data-end=\"4698\" data-start=\"4525\"\u003eMultiple rodent and porcine models show \u003cstrong data-end=\"4583\" data-start=\"4565\"\u003efaster closure\u003c\/strong\u003e, \u003cstrong data-end=\"4614\" data-start=\"4585\"\u003eimproved tensile strength\u003c\/strong\u003e, and \u003cstrong data-end=\"4636\" data-start=\"4620\"\u003ereduced scar\u003c\/strong\u003e with fragment dosing vs control, paralleling full-length Tβ4.\u003c\/p\u003e\n\u003ch3 data-end=\"4725\" data-start=\"4700\"\u003e4.2 Musculoskeletal\u003c\/h3\u003e\n\u003cp data-end=\"4918\" data-start=\"4726\"\u003eIn tendon laceration\/overuse models, fragment treatment improved \u003cstrong data-end=\"4821\" data-start=\"4791\"\u003ecollagen fibre orientation\u003c\/strong\u003e and \u003cstrong data-end=\"4845\" data-start=\"4826\"\u003eload-to-failure\u003c\/strong\u003e; functional recovery was enhanced when combined with \u003cstrong data-end=\"4917\" data-start=\"4899\"\u003egraded loading\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch3 data-end=\"4944\" data-start=\"4920\"\u003e4.3 Ocular Surface\u003c\/h3\u003e\n\u003cp data-end=\"5082\" data-start=\"4945\"\u003eTopical derivatives accelerated \u003cstrong data-end=\"5009\" data-start=\"4977\"\u003ecorneal re-epithelialization\u003c\/strong\u003e, decreased \u003cstrong data-end=\"5038\" data-start=\"5021\"\u003epain\/staining\u003c\/strong\u003e, and supported \u003cstrong data-end=\"5072\" data-start=\"5054\"\u003esubbasal nerve\u003c\/strong\u003eregrowth.\u003c\/p\u003e\n\u003cblockquote data-end=\"5270\" data-start=\"5084\"\u003e\n\u003cp data-end=\"5270\" data-start=\"5086\"\u003e\u003cstrong data-end=\"5112\" data-start=\"5086\"\u003eEvidence quality note:\u003c\/strong\u003e Most data are \u003cstrong data-end=\"5143\" data-start=\"5127\"\u003epre-clinical\u003c\/strong\u003e or \u003cstrong data-end=\"5182\" data-start=\"5147\"\u003eearly clinical\/ophthalmic pilot\u003c\/strong\u003e; standardized, placebo-controlled human trials for musculoskeletal uses remain limited.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-end=\"5275\" data-start=\"5272\"\u003e\n\u003ch2 data-end=\"5310\" data-start=\"5277\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"5827\" data-start=\"5312\"\u003e\n\u003cthead data-end=\"5350\" data-start=\"5312\"\u003e\n\u003ctr data-end=\"5350\" data-start=\"5312\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5320\" data-start=\"5312\"\u003eField\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"5332\" data-start=\"5320\"\u003eRationale\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5350\" data-start=\"5332\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"5827\" data-start=\"5365\"\u003e\n\u003ctr data-end=\"5476\" data-start=\"5365\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5396\" data-start=\"5365\"\u003e\u003cstrong data-end=\"5395\" data-start=\"5367\"\u003eChronic wounds (DFU\/VLU)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5446\" data-start=\"5396\" data-col-size=\"md\"\u003ePro-migration + antibiofilm-friendly remodeling\u003c\/td\u003e\n\u003ctd data-end=\"5476\" data-start=\"5446\" data-col-size=\"sm\"\u003eEarly clinical\/feasibility\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5581\" data-start=\"5477\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5505\" data-start=\"5477\"\u003e\u003cstrong data-end=\"5504\" data-start=\"5479\"\u003eTendon\/ligament rehab\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5550\" data-start=\"5505\" data-col-size=\"md\"\u003eFaster matrix repair with better alignment\u003c\/td\u003e\n\u003ctd data-end=\"5581\" data-start=\"5550\" data-col-size=\"sm\"\u003ePre-clinical → small series\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5665\" data-start=\"5582\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5612\" data-start=\"5582\"\u003e\u003cstrong data-end=\"5611\" data-start=\"5584\"\u003eCorneal disease\/dry eye\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5638\" data-start=\"5612\" data-col-size=\"md\"\u003eEpithelial\/nerve repair\u003c\/td\u003e\n\u003ctd data-end=\"5665\" data-start=\"5638\" data-col-size=\"sm\"\u003eEarly ophthalmic pilots\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5746\" data-start=\"5666\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5689\" data-start=\"5666\"\u003e\u003cstrong data-end=\"5688\" data-start=\"5668\"\u003eCardiac ischemia\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5730\" data-start=\"5689\" data-col-size=\"md\"\u003eCytoprotection + microvascular support\u003c\/td\u003e\n\u003ctd data-end=\"5746\" data-start=\"5730\" data-col-size=\"sm\"\u003ePre-clinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5827\" data-start=\"5747\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5769\" data-start=\"5747\"\u003e\u003cstrong data-end=\"5768\" data-start=\"5749\"\u003eScar modulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5797\" data-start=\"5769\" data-col-size=\"md\"\u003eAnti-fibrotic remodelling\u003c\/td\u003e\n\u003ctd data-end=\"5827\" data-start=\"5797\" data-col-size=\"sm\"\u003ePre-clinical\/observational\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"5832\" data-start=\"5829\"\u003e\n\u003ch2 data-end=\"5863\" data-start=\"5834\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"6371\" data-start=\"5865\"\u003e\n\u003cli data-end=\"5974\" data-start=\"5865\"\u003e\n\u003cp data-end=\"5974\" data-start=\"5867\"\u003e\u003cstrong data-end=\"5886\" data-start=\"5867\"\u003eCommon (local):\u003c\/strong\u003e Mild \u003cstrong data-end=\"5921\" data-start=\"5892\"\u003einjection-site irritation\u003c\/strong\u003e or \u003cstrong data-end=\"5937\" data-start=\"5925\"\u003estinging\u003c\/strong\u003e with topicals; transient erythema.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6076\" data-start=\"5975\"\u003e\n\u003cp data-end=\"6076\" data-start=\"5977\"\u003e\u003cstrong data-end=\"5990\" data-start=\"5977\"\u003eSystemic:\u003c\/strong\u003e Limited data; short peptides generally well tolerated in animals at research doses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6278\" data-start=\"6077\"\u003e\n\u003cp data-end=\"6278\" data-start=\"6079\"\u003e\u003cstrong data-end=\"6104\" data-start=\"6079\"\u003eTheoretical cautions:\u003c\/strong\u003e \u003cstrong data-end=\"6123\" data-start=\"6105\"\u003ePro-angiogenic\u003c\/strong\u003e activity may be undesirable in \u003cstrong data-end=\"6176\" data-start=\"6155\"\u003eactive malignancy\u003c\/strong\u003e or \u003cstrong data-end=\"6211\" data-start=\"6180\"\u003eproliferative retinopathies\u003c\/strong\u003e; monitor for \u003cstrong data-end=\"6250\" data-start=\"6225\"\u003eexuberant granulation\u003c\/strong\u003e in high-dose topical use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6371\" data-start=\"6279\"\u003e\n\u003cp data-end=\"6371\" data-start=\"6281\"\u003e\u003cstrong data-end=\"6300\" data-start=\"6281\"\u003eQuality\/purity:\u003c\/strong\u003e Grey-market products vary; prefer \u003cstrong data-end=\"6348\" data-start=\"6335\"\u003eGMP-grade\u003c\/strong\u003e materials in research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"6402\" data-start=\"6373\"\u003e\u003cstrong data-end=\"6402\" data-start=\"6373\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_sk2ct_1\"\u003e\n\u003cdiv class=\"_tableWrapper_sk2ct_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"6965\" data-start=\"6404\"\u003e\n\u003cthead data-end=\"6495\" data-start=\"6404\"\u003e\n\u003ctr data-end=\"6495\" data-start=\"6404\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6414\" data-start=\"6404\"\u003eConcern\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6450\" data-start=\"6414\"\u003e\u003cstrong data-end=\"6449\" data-start=\"6416\"\u003eTβ4 Frag 17–24 (TB-500-class)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6480\" data-start=\"6450\"\u003e\u003cstrong data-end=\"6479\" data-start=\"6452\"\u003eFull-length Tβ4 (43 aa)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"6495\" data-start=\"6480\"\u003e\u003cstrong data-end=\"6493\" data-start=\"6482\"\u003eBPC-157\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"6965\" data-start=\"6514\"\u003e\n\u003ctr data-end=\"6630\" data-start=\"6514\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6524\" data-start=\"6514\"\u003eSize\/PK\u003c\/td\u003e\n\u003ctd data-end=\"6558\" data-start=\"6524\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6557\" data-start=\"6526\"\u003eShort; very rapid clearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6586\" data-start=\"6558\" data-col-size=\"sm\"\u003eLonger; still short-lived\u003c\/td\u003e\n\u003ctd data-end=\"6630\" data-start=\"6586\" data-col-size=\"sm\"\u003eShort; GI stability claims (preclinical)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6714\" data-start=\"6631\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6646\" data-start=\"6631\"\u003eAngiogenesis\u003c\/td\u003e\n\u003ctd data-end=\"6670\" data-start=\"6646\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6669\" data-start=\"6648\"\u003eYes (VEGF\/HIF-1α)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6693\" data-start=\"6670\" data-col-size=\"sm\"\u003eYes (often stronger)\u003c\/td\u003e\n\u003ctd data-end=\"6714\" data-start=\"6693\" data-col-size=\"sm\"\u003eContext-dependent\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6802\" data-start=\"6715\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6738\" data-start=\"6715\"\u003eTendon\/ligament data\u003c\/td\u003e\n\u003ctd data-end=\"6761\" data-start=\"6738\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6760\" data-start=\"6740\"\u003eGood preclinical\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6782\" data-start=\"6761\" data-col-size=\"sm\"\u003eRobust preclinical\u003c\/td\u003e\n\u003ctd data-end=\"6802\" data-start=\"6782\" data-col-size=\"sm\"\u003eGood preclinical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6894\" data-start=\"6803\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6820\" data-start=\"6803\"\u003eHuman evidence\u003c\/td\u003e\n\u003ctd data-end=\"6839\" data-start=\"6820\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6838\" data-start=\"6822\"\u003eSparse\/early\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6870\" data-start=\"6839\" data-col-size=\"sm\"\u003eEarly ophthalmic\/derm pilots\u003c\/td\u003e\n\u003ctd data-end=\"6894\" data-start=\"6870\" data-col-size=\"sm\"\u003eSparse\/heterogeneous\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6965\" data-start=\"6895\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6915\" data-start=\"6895\"\u003eRegulatory status\u003c\/td\u003e\n\u003ctd data-end=\"6934\" data-start=\"6915\" data-col-size=\"sm\"\u003e\u003cstrong data-end=\"6933\" data-start=\"6917\"\u003eNot approved\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6949\" data-start=\"6934\" data-col-size=\"sm\"\u003eNot approved\u003c\/td\u003e\n\u003ctd data-end=\"6965\" data-start=\"6949\" data-col-size=\"sm\"\u003eNot approved\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"6970\" data-start=\"6967\"\u003e\n\u003ch2 data-end=\"6998\" data-start=\"6972\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"7331\" data-start=\"7000\"\u003e\n\u003cli data-end=\"7041\" data-start=\"7000\"\u003e\n\u003cp data-end=\"7041\" data-start=\"7002\"\u003e\u003cstrong data-end=\"7016\" data-start=\"7002\"\u003eApprovals:\u003c\/strong\u003e None in major markets.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7170\" data-start=\"7042\"\u003e\n\u003cp data-end=\"7170\" data-start=\"7044\"\u003e\u003cstrong data-end=\"7055\" data-start=\"7044\"\u003eAccess:\u003c\/strong\u003e Research\/compounded channels; \u003cstrong data-end=\"7094\" data-start=\"7086\"\u003eWADA\u003c\/strong\u003e generally prohibits \u003cstrong data-end=\"7154\" data-start=\"7115\"\u003enon-approved growth-repair peptides\u003c\/strong\u003e under \u003cstrong data-end=\"7167\" data-start=\"7161\"\u003eS0\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7331\" data-start=\"7171\"\u003e\n\u003cp data-end=\"7331\" data-start=\"7173\"\u003e\u003cstrong data-end=\"7198\" data-start=\"7173\"\u003eClinical development:\u003c\/strong\u003e Ophthalmic\/topical formulations of \u003cstrong data-end=\"7258\" data-start=\"7234\"\u003eTβ4-derived peptides\u003c\/strong\u003e are the furthest along; musculoskeletal indications lack pivotal trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7336\" data-start=\"7333\"\u003e\n\u003ch2 data-end=\"7361\" data-start=\"7338\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-end=\"8073\" data-start=\"7363\"\u003e\n\u003cli data-end=\"7497\" data-start=\"7363\"\u003e\n\u003cp data-end=\"7497\" data-start=\"7365\"\u003e\u003cstrong data-end=\"7393\" data-start=\"7365\"\u003eFormulation engineering:\u003c\/strong\u003e \u003cstrong data-end=\"7441\" data-start=\"7394\"\u003eHydrogels, microneedles, collagen scaffolds\u003c\/strong\u003e, or \u003cstrong data-end=\"7469\" data-start=\"7446\"\u003eslow-release depots\u003c\/strong\u003e to extend local exposure.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7632\" data-start=\"7498\"\u003e\n\u003cp data-end=\"7632\" data-start=\"7500\"\u003e\u003cstrong data-end=\"7524\" data-start=\"7500\"\u003eHead-to-head trials:\u003c\/strong\u003e Fragment vs \u003cstrong data-end=\"7556\" data-start=\"7537\"\u003efull-length Tβ4\u003c\/strong\u003e vs \u003cstrong data-end=\"7577\" data-start=\"7560\"\u003estandard care\u003c\/strong\u003e in \u003cstrong data-end=\"7592\" data-start=\"7581\"\u003eDFU\/VLU\u003c\/strong\u003e and \u003cstrong data-end=\"7622\" data-start=\"7597\"\u003eAchilles\/rotator-cuff\u003c\/strong\u003erepair.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7788\" data-start=\"7633\"\u003e\n\u003cp data-end=\"7788\" data-start=\"7635\"\u003e\u003cstrong data-end=\"7662\" data-start=\"7635\"\u003eMechanistic biomarkers:\u003c\/strong\u003e \u003cstrong data-end=\"7683\" data-start=\"7663\"\u003eMMP-2\/9 activity\u003c\/strong\u003e, \u003cstrong data-end=\"7693\" data-start=\"7685\"\u003eVEGF\u003c\/strong\u003e, \u003cstrong data-end=\"7721\" data-start=\"7695\"\u003eangiographic perfusion\u003c\/strong\u003e, \u003cstrong data-end=\"7750\" data-start=\"7723\"\u003eshear-wave elastography\u003c\/strong\u003e, and \u003cstrong data-end=\"7785\" data-start=\"7756\"\u003epatient-reported function\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7928\" data-start=\"7789\"\u003e\n\u003cp data-end=\"7928\" data-start=\"7791\"\u003e\u003cstrong data-end=\"7815\" data-start=\"7791\"\u003eCombination therapy:\u003c\/strong\u003e Pair with \u003cstrong data-end=\"7847\" data-start=\"7826\"\u003eeccentric loading\u003c\/strong\u003e, \u003cstrong data-end=\"7856\" data-start=\"7849\"\u003ePRP\u003c\/strong\u003e, or \u003cstrong data-end=\"7876\" data-start=\"7861\"\u003eLL-37-based\u003c\/strong\u003e wound care for antibiofilm + pro-healing synergy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8073\" data-start=\"7929\"\u003e\n\u003cp data-end=\"8073\" data-start=\"7931\"\u003e\u003cstrong data-end=\"7955\" data-start=\"7931\"\u003eSafety surveillance:\u003c\/strong\u003e Focus on \u003cstrong data-end=\"7995\" data-start=\"7965\"\u003eangiogenesis-related risks\u003c\/strong\u003e, \u003cstrong data-end=\"8026\" data-start=\"7997\"\u003eocular neovascularization\u003c\/strong\u003e, and \u003cstrong data-end=\"8055\" data-start=\"8032\"\u003etumour surveillance\u003c\/strong\u003ein long-term use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8078\" data-start=\"8075\"\u003e\n\u003ch3 data-end=\"8103\" data-start=\"8080\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"8885\" data-start=\"8105\"\u003e\n\u003cli data-end=\"8242\" data-start=\"8105\"\u003e\n\u003cp data-end=\"8242\" data-start=\"8107\"\u003e\u003cstrong data-end=\"8176\" data-start=\"8107\"\u003eWound Repair \u0026amp; Regeneration; Journal of Investigative Dermatology\u003c\/strong\u003e — Cutaneous healing and keratinocyte migration with Tβ4 motifs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8337\" data-start=\"8243\"\u003e\n\u003cp data-end=\"8337\" data-start=\"8245\"\u003e\u003cstrong data-end=\"8285\" data-start=\"8245\"\u003eCirculation; Cardiovascular Research\u003c\/strong\u003e — Cytoprotection\/angiogenesis in ischemic models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8480\" data-start=\"8338\"\u003e\n\u003cp data-end=\"8480\" data-start=\"8340\"\u003e\u003cstrong data-end=\"8412\" data-start=\"8340\"\u003eAmerican Journal of Sports Medicine; Journal of Orthopaedic Research\u003c\/strong\u003e — Tendon\/ligament repair biomechanics under Tβ4-derived peptides.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8597\" data-start=\"8481\"\u003e\n\u003cp data-end=\"8597\" data-start=\"8483\"\u003e\u003cstrong data-end=\"8539\" data-start=\"8483\"\u003eInvestigative Ophthalmology \u0026amp; Visual Science; Cornea\u003c\/strong\u003e — Corneal epithelial\/nerve repair with Tβ4 derivatives.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8698\" data-start=\"8598\"\u003e\n\u003cp data-end=\"8698\" data-start=\"8600\"\u003e\u003cstrong data-end=\"8648\" data-start=\"8600\"\u003eJournal of Immunology; Inflammation Research\u003c\/strong\u003e — NF-κB modulation and macrophage polarization.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8788\" data-start=\"8699\"\u003e\n\u003cp data-end=\"8788\" data-start=\"8701\"\u003e\u003cstrong data-end=\"8749\" data-start=\"8701\"\u003eMatrix Biology; Fibrogenesis \u0026amp; Tissue Repair\u003c\/strong\u003e — Anti-fibrotic remodeling pathways.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8885\" data-start=\"8789\"\u003e\n\u003cp data-end=\"8885\" data-start=\"8791\"\u003e\u003cstrong data-end=\"8824\" data-start=\"8791\"\u003eFASEB Journal; Muscle \u0026amp; Nerve\u003c\/strong\u003e — Skeletal muscle regeneration and satellite-cell migration.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684852494674,"sku":null,"price":90.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/tb400_frag-17-24.png?v=1770834856","url":"https:\/\/sciencepeptideslab.com\/products\/thymosin-%ce%b24-fragment-17-24-10mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}